Results 61 to 70 of about 7,195 (251)
Aim Londamocitinib (AZD4604) is an inhaled, selective Janus kinase 1 (JAK1) inhibitor in development for asthma. This open‐label, two‐part, phase I clinical study (NCT06157255) used a radiolabelled microtracer approach to evaluate the absolute bioavailability and the absorption, distribution, metabolism and excretion (ADME) of inhaled londamocitinib ...
Camille Riff +12 more
wiley +1 more source
Green construction practices (GCPs) are essential for the construction industry to achieve carbon neutral and sustainable development. However, the promotion of GCPs faces multifaceted challenges, particularly within the context of recent global ...
Chaofan Wang +5 more
doaj +1 more source
Greig cephalopolysyndactyly syndrome (GCPS) is an autosomal dominant disorder with polydactyly and syndactyly of the limbs and a broad spectrum of craniofacial abnormalities.
Lotta eVeistinen +5 more
doaj +1 more source
Aims Elecoglipron (AZD5004/ECC5004) is an oral small‐molecule glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in development for weight management in people living with obesity or overweight and type 2 diabetes. This study aimed to characterize the pharmacokinetics (PK) profiles of two formulations of elecoglipron under fed and fasted conditions ...
Jianfeng Xu +13 more
wiley +1 more source
This study was designed to develop a nanogel formulation incorporating acyclovir and lignocaine (ALN). Various formulations were developed in which ALN-V (formulation-V) was optimized.
Adnan Aslam +3 more
doaj +1 more source
mGFP-labeled, postmitotic migrating GCPs in the EGL with trailing and leading processes at P8.
Left: P3-injected P8 cerebellum, mGFP = cells after recombination, mTomato = cells without recombination. Frames A-C are shown enlarged, A′-C′ = further enlargement to show mGFP-immunoreactive GCPs in the inner EGL, A″-C″ = mTomato. Arrowheads in
Thomas Günther (247952) +7 more
core +1 more source
Safety and pharmacokinetics of inhaled aloxistatin: A first‐in‐human phase 1 dose escalation trial
Aims Aloxistatin (E64d) is a membrane‐permeable cysteine protease inhibitor prodrug that is converted by esterases to the active metabolite E64c (loxistatin). This first‐in‐human study evaluated the safety, tolerability and pharmacokinetics of single ascending doses of inhaled E64d in healthy volunteers.
Sebastian Fähndrich +24 more
wiley +1 more source
With the advent of very high-resolution (VHR) imaging satellites, it is possible to measure the heights of forest stands or even individual trees more accurately.
Wenjian Ni +8 more
doaj +1 more source
The use of small UAV (Unmanned Aerial Vehicle) and Structure-from-Motion (SfM) with Multi-View Stereopsis (MVS) for acquiring survey datasets is now commonplace, however, aspects of the SfM-MVS workflow require further validation.
Toby N. Tonkin, Nicholas G. Midgley
doaj +1 more source
Oral microbial homeostasis, a dynamic host‐microbe balance, is vital in infectious diseases. Conventional antibiotics often disrupt this homeostasis, spurring interest in nanomaterials for oral microbial homeostasis rebalancing. This review outlines nanomaterial strategies across three ecological levels (population/community, ecosystem, and cross ...
Chen Hu +10 more
wiley +1 more source

